- Home
- INKT vs IINN Comparison
INKT vs IINN Comparison
Compare INKT & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- IINN
- Stock Information
- Founded
- INKT 2017
- IINN 2018
- Country
- INKT United States
- IINN Israel
- Employees
- INKT N/A
- IINN N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- IINN Medical/Dental Instruments
- Sector
- INKT Health Care
- IINN Health Care
- Exchange
- INKT Nasdaq
- IINN Nasdaq
- Market Cap
- INKT 28.5M
- IINN 25.9M
- IPO Year
- INKT 2021
- IINN 2021
- Fundamental
- Price
- INKT $0.75
- IINN $1.22
- Analyst Decision
- INKT Strong Buy
- IINN
- Analyst Count
- INKT 2
- IINN 0
- Target Price
- INKT $6.50
- IINN N/A
- AVG Volume (30 Days)
- INKT 32.0K
- IINN 139.8K
- Earning Date
- INKT 11-14-2024
- IINN 08-15-2024
- Dividend Yield
- INKT N/A
- IINN N/A
- EPS Growth
- INKT N/A
- IINN N/A
- EPS
- INKT N/A
- IINN N/A
- Revenue
- INKT N/A
- IINN N/A
- Revenue This Year
- INKT N/A
- IINN N/A
- Revenue Next Year
- INKT N/A
- IINN N/A
- P/E Ratio
- INKT N/A
- IINN N/A
- Revenue Growth
- INKT N/A
- IINN N/A
- 52 Week Low
- INKT $0.57
- IINN $0.76
- 52 Week High
- INKT $1.90
- IINN $2.49
- Technical
- Relative Strength Index (RSI)
- INKT 54.46
- IINN 37.10
- Support Level
- INKT $0.74
- IINN $1.25
- Resistance Level
- INKT $0.80
- IINN $1.45
- Average True Range (ATR)
- INKT 0.05
- IINN 0.08
- MACD
- INKT 0.01
- IINN -0.01
- Stochastic Oscillator
- INKT 62.60
- IINN 17.83
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.